Evaluation of FOCEI and SAEM Estimation Methods in Population Pharmacokinetic Analysis Using NONMEM® Across Rich, Medium, and Sparse Sampling Data

被引:10
|
作者
Sukarnjanaset, Waroonrat [1 ]
Wattanavijitkul, Thitima [1 ]
Jarurattanasirikul, Sutep [2 ]
机构
[1] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Pharm Practice, 254 Phyathai Rd, Bangkok 10330, Thailand
[2] Prince Songkla Univ, Dept Med, Fac Med, Hat Yai, Thailand
关键词
MAXIMUM-LIKELIHOOD; PERFORMANCE; PHARMACODYNAMICS;
D O I
10.1007/s13318-018-0484-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and ObjectivesFirst-order conditional estimation with interaction (FOCEI) is one of the most commonly used estimation methods in nonlinear mixed effects modeling, while the stochastic approximation expectation maximization (SAEM) is the newer estimation algorithm. This work aimed to compare the performance of FOCEI and SAEM methods when using NONMEM (R) with the classical one- and two-compartment models across rich, medium, and sparse data.MethodsOne- and two-compartment models of the previous studies were used to simulate data in three scenarios: rich, medium, and sparse data. For each scenario, there were 100 data sets, containing 100 individuals in each data set. Every data set was estimated with both FOCEI and SAEM methods. The simulation and estimation were performed using NONMEM (R). The completion rates, percentage of relative estimation errors (%RERs), root mean square errors (RMSEs), and runtimes were considered to assess the completion, accuracy, precision, and speed of estimation, respectively.ResultsBoth FOCEI and SAEM methods provided comparable completion rates, median %RERs (ranged from -9.03 to 3.27% for FOCEI and -9.17to3.27% for SAEM) and RMSEs (ranged from 0.0004 to 1.244 for FOCEI and 0.0004to1.131 for SAEM) for most parameters in both models across three scenarios. The run times were much shorter with FOCEI (ranged from 0.18 to 0.98min) compared to SAEM method (ranged from 4.64 to 12.03min).ConclusionsFor the classical one- and two-compartment models, FOCEI method exhibited comparable performance similar to SAEM method but with significantly shorter runtimes across rich, medium, and sparse sampling scenarios.
引用
收藏
页码:729 / 736
页数:8
相关论文
共 21 条
  • [1] Evaluation of FOCEI and SAEM Estimation Methods in Population Pharmacokinetic Analysis Using NONMEM® Across Rich, Medium, and Sparse Sampling Data
    Waroonrat Sukarnjanaset
    Thitima Wattanavijitkul
    Sutep Jarurattanasirikul
    European Journal of Drug Metabolism and Pharmacokinetics, 2018, 43 : 729 - 736
  • [2] Analysis of population pharmacokinetic data using NONMEM and WinBUGS
    Duffull, SB
    Kirkpatrick, CMJ
    Green, B
    Holford, NHG
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2005, 15 (01) : 53 - 73
  • [3] Estimation Methods for Population Pharmacokinetic Models using Stochastic Sampling Approach
    Kim, Kwang-Hee
    Yoon, Jeong-Hwa
    Lee, Eun-Kyung
    KOREAN JOURNAL OF APPLIED STATISTICS, 2015, 28 (02) : 175 - 188
  • [4] Random sparse sampling strategy using stochastic simulation and estimation for a population pharmacokinetic study
    Huang, Xiao-hui
    Wang, Kun
    Huang, Ji-han
    Xu, Ling
    Li, Lu-jin
    Sheng, Yu-cheng
    Zheng, Qing-shan
    SAUDI PHARMACEUTICAL JOURNAL, 2014, 22 (01) : 63 - 69
  • [5] EVALUATION OF BAYESIAN-ESTIMATION IN COMPARISON TO NONMEM FOR POPULATION PHARMACOKINETIC DATA-ANALYSIS - APPLICATION TO PEFLOXACIN IN INTENSIVE-CARE UNIT PATIENTS
    BRUNO, R
    ILIADIS, MC
    LACARELLE, B
    COSSON, V
    MANDEMA, JW
    LEROUX, Y
    MONTAY, G
    DURAND, A
    BALLEREAU, M
    ALASIA, M
    ALBANESE, J
    FRANCOIS, G
    ILIADIS, A
    FRYDMAN, A
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1992, 20 (06): : 653 - 669
  • [6] Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling
    Feng, Y
    Pollock, BG
    Ferrell, RE
    Kimak, MA
    Reynolds, CF
    Bies, RR
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (05) : 558 - 569
  • [7] Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study
    Feng, Yan
    Pollock, Bruce G.
    Coley, Kim
    Marder, Stephen
    Miller, Del
    Kirshner, Margaret
    Aravagiri, Manickam
    Schneider, Lon
    Bies, Robert R.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (05) : 629 - 639
  • [8] The Influence of Sparse Data Sampling on Population Pharmacokinetics: A Post Hoc Analysis of a Pharmacokinetic Study of Morphine in Healthy Volunteers
    Ariano, Robert E.
    Duke, Peter C.
    Sitar, Daniel S.
    CLINICAL THERAPEUTICS, 2012, 34 (03) : 668 - 676
  • [9] Evaluation of the estimation of midazolam concentrations and pharmacokinetic parameters in intensive care patients using a bayesian pharmacokinetic software (PKS) according to sparse sampling approach
    Bolon, M
    Bastien, O
    Flamens, C
    Paulus, S
    Salord, F
    Boulieu, R
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2003, 55 (06) : 765 - 771
  • [10] A PHARMACOKINETIC EVALUATION OF VANCOMYCIN IN VERY-LOW-BIRTH-WEIGHT INFANTS USING ROUTINE DRUG CONCENTRATION DATA AND NONMEM ANALYSIS
    NILMEIER, N
    PROBER, C
    SALE, M
    BLASCHKE, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 144 - 144